Saralasin Acetate

醋酸肌丙抗增压素

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSaralasin Acetate
Drug Alias Name醋酸沙拉新saralasinesaralasinasaralasinumSarenin +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II receptor type 2 antagonists
TargetsAngiotensin II receptor type 2
Therapy Area/IndicationsDiagnostic agents
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesProcter & Gamble Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProcter & Gamble Company
Active IndicationsN/A
Inactive IndicationsDiagnostic agents

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG